If you’re just getting started with options, you might have learned the hard way about the different levels of trading. That could happen, for example, if you tried to place a spread order only to be informed by your trading platform that you’re not approved for Level 3 options trading. Read More

As the world increasingly abandons “dead tree media,” Adobe (NSDQ: ADBE) continues to innovate and build out its platforms, to the point where it is now the primary provider of diversified tools for digital publishing. For many people, the only interaction they have with Adobe is through its ubiquitous PDF… Read More

Salesforce (NYSE: CRM) has suffered a slew of detractors over the years. Analysts have repeatedly argued that the company is overvalued or would never survive. And yet, here it is, still going strong. Salesforce is a prime example of a company that stuck to its knitting, pursued its vision, and… Read More

AbbVie (NYSE: ABBV) is a $135 billion market cap biotech, making it a “Big Pharma” player. Despite its mammoth size, can this blue-chip drug maker generate outsized growth? Or is AbbVie’s best days behind it? The question takes on added urgency, as the overall stock market gyrates amid growing headline… Read More

At first glance, cannabis company KushCo Holdings (OTC: KSHB) is a pleasant surprise. KushCo appears to be a real business, with growing revenue, and isn’t a penny stock. These qualities help distinguish the company from many marijuana stocks, which are shaky ventures built on hype. KushCo also… Read More

The marijuana industry is in the midst of a classic bubble, reminiscent of the dot.com boom (and bust) of the late 1990s. To be sure, “canna-business” represents one of the greatest investment opportunities you’ll see in your lifetime and certain marijuana stocks offer the potential for exponential gains. However, investors… Read More

How would you like to earn a healthy return from a stock that you think will rise modestly in the near future? If so, then you should check out the long broken butterfly strategy. As the name implies, a long broken butterfly (or long skip-strike butterfly) is based on the… Read More

The exploding marijuana industry is rife with indirect plays that could be safer bets on growth because they’re involved in non-cannabis niches as well. One such stock is Psychemedics (NSDQ: PMD), a drug-testing firm. Unlike many direct marijuana opportunities, this firm is generating real revenue and profits. The question is… Read More

How would you like to profit from a stock that you think will rise significantly in the short term while limiting your loss if it tanks? If so, then you should check out the short broken butterfly options strategy. As the name implies, a short broken butterfly (or short skip-strike… Read More

The marijuana boom is one of the greatest investment frenzies we’ve seen since the dot.com bubble of the late 1990s. Will the “green rush” end the same way, with pain for investors? You can make a lot of money in cannabis, as long as you remain prudent in your stock… Read More